200 related articles for article (PubMed ID: 14736092)
21. Interaction of inhaled beta 2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine.
Cockcroft DW; Swystun VA; Bhagat R
Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1485-9. PubMed ID: 7582281
[TBL] [Abstract][Full Text] [Related]
22. The utility of methacholine airway responsiveness measurements in evaluating anti-asthma drugs.
Inman MD; Hamilton AL; Kerstjens HA; Watson RM; O'Byrne PM
J Allergy Clin Immunol; 1998 Mar; 101(3):342-8. PubMed ID: 9525450
[TBL] [Abstract][Full Text] [Related]
23. The protective effect of a beta 2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease.
Bel EH; Zwinderman AH; Timmers MC; Dijkman JH; Sterk PJ
Thorax; 1991 Jan; 46(1):9-14. PubMed ID: 1871705
[TBL] [Abstract][Full Text] [Related]
24. Preserved bronchial dilatation after salbutamol does not guarantee protection against bronchial hyperresponsiveness.
Sjöswärd KN; Josefsson M; Ahlner J; Schmekel B
Clin Physiol Funct Imaging; 2003 Jan; 23(1):14-20. PubMed ID: 12558609
[TBL] [Abstract][Full Text] [Related]
25. Salbutamol-induced increased airway responsiveness to allergen and reduced protection versus methacholine: dose response.
Bhagat R; Swystun VA; Cockcroft DW
J Allergy Clin Immunol; 1996 Jan; 97(1 Pt 1):47-52. PubMed ID: 8568137
[TBL] [Abstract][Full Text] [Related]
26. Selective subsensitization of beta-adrenergic receptors in central airways of asthmatics and normal subjects during long-term therapy with inhaled salbutamol.
Conolly ME; Tashkin DP; Hui KK; Littner MR; Wolfe RN
J Allergy Clin Immunol; 1982 Dec; 70(6):423-31. PubMed ID: 6292279
[TBL] [Abstract][Full Text] [Related]
27. Persistence of airway obstruction and hyperresponsiveness in subjects with asthma remission.
Boulet LP; Turcotte H; Brochu A
Chest; 1994 Apr; 105(4):1024-31. PubMed ID: 8162720
[TBL] [Abstract][Full Text] [Related]
28. Bronchial responsiveness to beta-adrenergic stimulation and enhanced beta-blockade in asthma.
Boskabady MH; Snashall PD
Respirology; 2000 Jun; 5(2):111-8. PubMed ID: 10894099
[TBL] [Abstract][Full Text] [Related]
29. Recognition of asthma in adolescents and young adults: which objective measure is best?
Ulrik CS; Postma DS; Backer V
J Asthma; 2005 Sep; 42(7):549-54. PubMed ID: 16169787
[TBL] [Abstract][Full Text] [Related]
30. Airway responsiveness to histamine and methacholine: relationship to minimum treatment to control symptoms of asthma.
Juniper EF; Frith PA; Hargreave FE
Thorax; 1981 Aug; 36(8):575-9. PubMed ID: 7031972
[TBL] [Abstract][Full Text] [Related]
31. The inhibitory effect of nebulized albuterol on the early and late asthmatic reactions and increase in airway responsiveness provoked by inhaled allergen in asthma.
Twentyman OP; Finnerty JP; Holgate ST
Am Rev Respir Dis; 1991 Oct; 144(4):782-7. PubMed ID: 1928949
[TBL] [Abstract][Full Text] [Related]
32. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
van der Woude HJ; Winter TH; Aalbers R
Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
[TBL] [Abstract][Full Text] [Related]
33. Regular inhaled salbutamol : effect on airway responsiveness to methacholine and adenosine 5'-monophosphate and tolerance to bronchoprotection.
Jokic R; Swystun VA; Davis BE; Cockcroft DW
Chest; 2001 Feb; 119(2):370-5. PubMed ID: 11171711
[TBL] [Abstract][Full Text] [Related]
34. Bronchodilator and bronchoprotective effects of salmeterol in young patients with asthma.
Simons FE; Soni NR; Watson WT; Becker AB
J Allergy Clin Immunol; 1992 Nov; 90(5):840-6. PubMed ID: 1358932
[TBL] [Abstract][Full Text] [Related]
35. Airway resistance at maximum inhalation as a marker of asthma and airway hyperresponsiveness.
Mendonça NT; Kenyon J; LaPrad AS; Syeda SN; O'Connor GT; Lutchen KR
Respir Res; 2011 Jul; 12(1):96. PubMed ID: 21762517
[TBL] [Abstract][Full Text] [Related]
36. Regular formoterol treatment in mild asthma. Effect on bronchial responsiveness during and after treatment.
Yates DH; Sussman HS; Shaw MJ; Barnes PJ; Chung KF
Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1170-4. PubMed ID: 7551366
[TBL] [Abstract][Full Text] [Related]
37. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
de Jong JW; van der Mark TW; Koëter GH; Postma DS
Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
[TBL] [Abstract][Full Text] [Related]
38. Effect of magnitude of airway responsiveness and therapy with inhaled corticosteroid on histamine tachyphylaxis in asthma.
Strban M; Manning PJ; Watson RM; O'Byrne PM
Chest; 1994 May; 105(5):1434-8. PubMed ID: 8181332
[TBL] [Abstract][Full Text] [Related]
39. Effect of regular inhaled salbutamol on airway responsiveness and airway inflammation in rhinitic non-asthmatic subjects.
Evans DW; Salome CM; King GG; Rimmer SJ; Seale JP; Woolcock AJ
Thorax; 1997 Feb; 52(2):136-42. PubMed ID: 9059473
[TBL] [Abstract][Full Text] [Related]
40. Formoterol, a new long-acting selective beta 2-adrenergic receptor agonist: double-blind comparison with salbutamol and placebo in children with asthma.
Becker AB; Simons FE
J Allergy Clin Immunol; 1989 Dec; 84(6 Pt 1):891-5. PubMed ID: 2574732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
